Analysts: Device companies already absorbed excise tax | MassDevice.com On Call

MassDevice.com On Call

MASSDEVICE.COM ON CALL — Many medical device companies have long petitioned for a repeal of the 2.3% excise tax on U.S. sales, but analysts say medtech companies have already managed to absorb the tax without taking a hit to the bottom line or jacking up costs for consumers.

Seven months into the tax, companies are instead coping by making layoffs, freezing salaries and restructuring. Many large medical device companies have landed headlines with exhaustive restructuring plans and sweeping layoffs.

An industry analysts from Bloomberg said experts agree the larger medical device companies will restructure rather than take suffer losses, according to The Morning Call.

 Brigham cardiac surgeon quits after road rage at Logan Airport
 Dr. Robert Rizzo, head of Brigham & Women’s Cape Cod Hospital cardiac surgery program, resigned in the wake of assault and battery charges. The troubles began for Rizzo last month as he waited to pick up his wife at Logan Airport, where he ran afoul of a Mass. state trooper, allegedly running over the trooper’s foot with his car.

The cardiologist drove off and was soon arrested in the Ted Williams Tunnel. Rizzo, who launched the open-heart surgery program at the Hyannis, Mass., hospital in 2002, quit both his position at the Brigham and at the Cape Cod hospital.
Read more

 Circumcision costs $2,110 at 1 hospital and $235 across town

A pediatrician in Anchorage calls the $2,110 price tag for a circumcision at Alaska Regional Hospital "wildly abnormal"
and is rallying 2 groups of pediatric physicians to stop conducting the simple procedure there. Across town, at Providence Hospital, a circumcision costs $250. Dr. Charles Ryan said the physicians in his group were quick to move their circumcision procedures into private offices after learning about the hefty bills to patients.
Read more

 A new app to move patients up on an organ transplant list

OrganJet Corp., a Weston, Mass.-based company, recently released an app that will help patients find a better spot in line for an organ transplant. In states like New Jersey, California, and Massachusetts, patients sometimes wait up to 5 years for an transplant, but other states have significantly shorter lists. The free OrganJet app matches patients with organ lists in nearby geographic regions so they can more affordably relocate and cut their wait time on the organ transplant list.
Read more

 Obamacare covers millions of uninsured young Americans

Out of the 15 million young Americans who enrolled in
parent’s healthcare plans last year, 7.8 million would not have been able to afford other insurance coverage, according to a new survey from the Commonwealth Fund. Contrary to popular belief, the survey found that a majority of young adults will choose to be insured if affordable. Only 5% said they would turn down employer-based coverage because they felt they didn’t need it. Commonwealth Fund VP Sara Collins said it is a myth that young adults are callous about healthcare coverage; rather, they value insurance but often cannot afford it.
Read more

RSS From Medical Design & Outsourcing

  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]
  • Sigma-Aldrich announces a new certification to aid IVD customers
    Sigma-Aldrich, a life science and high technology company, announced the company has received ISO 13485 certification for expanded quality assurance capabilities at its Dekalb and Barton facilities located in St. Louis. The certification extends Sigma-Aldrich’s ability to manufacture and offer critical raw materials, such as enzymes, proteins and antibodies used in diagnostic assays, and supplies in vitro […]
  • Prescribing the right power supply: Important considerations for using batteries to power medical devices
    Sol Jacobs, VP and General Manager, Tadiran Batteries Medical technology is advancing rapidly, requiring increasingly sophisticated power management solutions, especially when then the device needs to be self-powered. Battery-powered medical devices encompass a wide range of applications, including surgical drills, power tools, automatic external defibrillators (AEDs), infusion pumps, bone growth stimulators and other wearable devices, […]
  • Qosina announces the launch of its e-commerce website
    Qosina is pleased to announce the launch of its e-commerce website, making it easier to purchase thousands of medical device components from stock inventory. Visitors coming to the new Qosina.com will discover a new look and feel and improvements with every click including: · Easy navigation: A new category structure that mirrors the print catalog […]
  • Athermal laser machining for medical implants is the topic of Norman Noble’s latest whitepaper
    Thermal lasers have achieved extraordinary results in microprecision manufacturing of medical implants and devices the past 20 years. Devices we take for granted today, such as vascular stents, could not be produced without the technology; however, there are still significant limitations on what medical implant and device manufactures can produce using thermal lasers. One major issue […]
  • Sealevel announces the SeaISO family of USB isolators
    Sealevel announces the SeaISO family of USB isolators with 4 kV of medical-grade optical isolation between the host computer and connected USB equipment. SeaISO USB isolators are UL Recognized, in accordance with EN60601-1 3rd Edition, and protect both the power and data lines of connected USB devices from harmful ground loops, damaging transients and surges […]
  • The 21st Century Cures Discussion document recently released to the public
    It has been reported that among the 10,000 known diseases, 7,000 of which are considered rare, there are treatments for only 500. According to Dr. Francis Collins, Director of the National Institutes of Health (NIH), it now takes “around 14 years and $2 billion or more” to develop a new drug and “more than 95% […]

Leave a Reply